These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

253 related articles for article (PubMed ID: 25625556)

  • 1. The orphan receptor NOR1 participates in isoprenaline-induced cardiac hypertrophy by regulating PARP-1.
    Feng XJ; Gao H; Gao S; Li Z; Li H; Lu J; Wang JJ; Huang XY; Liu M; Zou J; Ye JT; Liu PQ
    Br J Pharmacol; 2015 Jun; 172(11):2852-63. PubMed ID: 25625556
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Differential transactivation by orphan nuclear receptor NOR1 and its fusion gene product EWS/NOR1: possible involvement of poly(ADP-ribose) polymerase I, PARP-1.
    Ohkura N; Nagamura Y; Tsukada T
    J Cell Biochem; 2008 Oct; 105(3):785-800. PubMed ID: 18680143
    [TBL] [Abstract][Full Text] [Related]  

  • 3. SIRT3 inhibits cardiac hypertrophy by regulating PARP-1 activity.
    Feng X; Wang Y; Chen W; Xu S; Li L; Geng Y; Shen A; Gao H; Zhang L; Liu S
    Aging (Albany NY); 2020 Mar; 12(5):4178-4192. PubMed ID: 32139662
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Salvianolic acid B protects cardiomyocytes from angiotensin II-induced hypertrophy via inhibition of PARP-1.
    Liu M; Ye J; Gao S; Fang W; Li H; Geng B; Zou J; Chen X; Chen S; Zhang L; Yue Z; Ma Y; Gao H; Li Z; Liu P
    Biochem Biophys Res Commun; 2014 Feb; 444(3):346-53. PubMed ID: 24462865
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The poly(ADP-ribosyl)ation of FoxO3 mediated by PARP1 participates in isoproterenol-induced cardiac hypertrophy.
    Lu J; Zhang R; Hong H; Yang Z; Sun D; Sun S; Guo X; Ye J; Li Z; Liu P
    Biochim Biophys Acta; 2016 Dec; 1863(12):3027-3039. PubMed ID: 27686254
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Astragaloside IV protects against isoproterenol-induced cardiac hypertrophy by regulating NF-κB/PGC-1α signaling mediated energy biosynthesis.
    Zhang S; Tang F; Yang Y; Lu M; Luan A; Zhang J; Yang J; Wang H
    PLoS One; 2015; 10(3):e0118759. PubMed ID: 25738576
    [TBL] [Abstract][Full Text] [Related]  

  • 7. COX-2 is involved in ET-1-induced hypertrophy of neonatal rat cardiomyocytes: role of NFATc3.
    Li H; Gao S; Ye J; Feng X; Cai Y; Liu Z; Lu J; Li Q; Huang X; Chen S; Liu P
    Mol Cell Endocrinol; 2014 Feb; 382(2):998-1006. PubMed ID: 24291639
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Antihypertrophic Effects of Nebivolol on Neonatal Cardiomyocyte Hypertrophy Models.
    Ozakca I
    J Cardiovasc Pharmacol; 2019 Mar; 73(3):155-164. PubMed ID: 30601193
    [TBL] [Abstract][Full Text] [Related]  

  • 9. PARP-2 knockdown protects cardiomyocytes from hypertrophy via activation of SIRT1.
    Geng B; Cai Y; Gao S; Lu J; Zhang L; Zou J; Liu M; Yu S; Ye J; Liu P
    Biochem Biophys Res Commun; 2013 Jan; 430(3):944-50. PubMed ID: 23261455
    [TBL] [Abstract][Full Text] [Related]  

  • 10. AG-690/11026014, a novel PARP-1 inhibitor, protects cardiomyocytes from AngII-induced hypertrophy.
    Liu M; Li Z; Chen GW; Li ZM; Wang LP; Ye JT; Luo HB; Liu PQ
    Mol Cell Endocrinol; 2014 Jul; 392(1-2):14-22. PubMed ID: 24859603
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Let-7a Is an Antihypertrophic Regulator in the Heart via Targeting Calmodulin.
    Zhou X; Sun F; Luo S; Zhao W; Yang T; Zhang G; Gao M; Lu R; Shu Y; Mu W; Zhuang Y; Ding F; Xu C; Lu Y
    Int J Biol Sci; 2017; 13(1):22-31. PubMed ID: 28123343
    [No Abstract]   [Full Text] [Related]  

  • 12. S100A8/MYD88/NF-қB: a novel pathway involved in cardiomyocyte hypertrophy driven by thyroid hormone.
    Takano APC; Munhoz CD; Moriscot AS; Gupta S; Barreto-Chaves MLM
    J Mol Med (Berl); 2017 Jun; 95(6):671-682. PubMed ID: 28161820
    [TBL] [Abstract][Full Text] [Related]  

  • 13. PKD deletion promotes autophagy and inhibits hypertrophy in cardiomyocyte.
    Zhao D; Gao Y; Wang W; Pei H; Xu C; Zhao Z
    Exp Cell Res; 2020 Jan; 386(2):111742. PubMed ID: 31759056
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Inducible cAMP early repressor (ICER) is a negative-feedback regulator of cardiac hypertrophy and an important mediator of cardiac myocyte apoptosis in response to beta-adrenergic receptor stimulation.
    Tomita H; Nazmy M; Kajimoto K; Yehia G; Molina CA; Sadoshima J
    Circ Res; 2003 Jul; 93(1):12-22. PubMed ID: 12791704
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects and mechanism of action of ligustrazine on isoprenaline-induced cardiomyocyte hypertrophy.
    Ji XX; Song XL; Qian W; Yu XL; Zhu JY
    Cell Biochem Biophys; 2014 Dec; 70(3):1513-8. PubMed ID: 25027096
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cyclin-Dependent Kinase Inhibitor p21WAF1/CIP1 Facilitates the Development of Cardiac Hypertrophy.
    Tong YF; Wang Y; Ding YY; Li JM; Pan XC; Lu XL; Chen XH; Liu Y; Zhang HG
    Cell Physiol Biochem; 2017; 42(4):1645-1656. PubMed ID: 28746924
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Ca2+-induced PARP-1 activation and ANF expression are coupled events in cardiomyocytes.
    Geistrikh I; Visochek L; Klein R; Miller L; Mittelman L; Shainberg A; Cohen-Armon M
    Biochem J; 2011 Sep; 438(2):337-47. PubMed ID: 21635224
    [TBL] [Abstract][Full Text] [Related]  

  • 18. MicroRNA-22 downregulation by atorvastatin in a mouse model of cardiac hypertrophy: a new mechanism for antihypertrophic intervention.
    Tu Y; Wan L; Bu L; Zhao D; Dong D; Huang T; Cheng Z; Shen B
    Cell Physiol Biochem; 2013; 31(6):997-1008. PubMed ID: 23860036
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of pioglitazone on the expression of inflammatory cytokines in attenuating rat cardiomyocyte hypertrophy.
    Ye P; Yang W; Wu SM; Sheng L
    Methods Find Exp Clin Pharmacol; 2006 Dec; 28(10):691-6. PubMed ID: 17235413
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Small heterodimer partner blocks cardiac hypertrophy by interfering with GATA6 signaling.
    Nam YS; Kim Y; Joung H; Kwon DH; Choe N; Min HK; Kim YS; Kim HS; Kim DK; Cho YK; Kim YH; Nam KI; Choi HC; Park DH; Suk K; Lee IK; Ahn Y; Lee CH; Choi HS; Eom GH; Kook H
    Circ Res; 2014 Aug; 115(5):493-503. PubMed ID: 25015078
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.